Corvus Capital Ltd.

10% OwnerCONDUIT PHARMACEUTICALS INC. (CDT) · full profile →Form 4 · filed Sep 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.6M
Net Open-Market Flow
-$4.6M
Transactions
12
12 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2024Sell(S)1.5M$0.26$394K178K
Jul 16, 2024Sell(S)10.2M$0.32$3.3M1.7M
Jul 15, 2024Sell(S)1.0M$0.25$251K11.9M
Jul 12, 2024Sell(S)1.4M$0.25$347K12.9M
Jul 11, 2024Sell(S)300K$0.29$87K14.3M
Jul 11, 2024Sell(S)583K$0.30$175K14.6M
Jul 10, 2024Sell(S)150K$0.33$50K15.2M
Jul 9, 2024Sell(S)78K$0.44$34K15.4M
Jul 8, 2024Sell(S)36K$0.51$18K15.4M
Jul 3, 2024Sell(S)1K$0.64$64015.5M
Jun 14, 2024Other(J)1.1M15.5M
Jun 14, 2024Other(J)1.1M30.0M

Transaction Codes

S
Open-market sale
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-037150) within minutes of acceptance. Every field above traces to the original document. Verify it directly: